PUTNAM INVESTMENTS LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2020$3,599,000
-2.6%
41,2560.0%0.01%
-12.5%
Q2 2020$3,695,000
-10.4%
41,256
-0.3%
0.01%
-27.3%
Q1 2020$4,125,000
-13.5%
41,396
-0.3%
0.01%
+10.0%
Q4 2019$4,771,000
-8.5%
41,516
+0.4%
0.01%
-16.7%
Q3 2019$5,214,000
+605.5%
41,336
+82.4%
0.01%
+500.0%
Q1 2014$739,000
-56.7%
22,657
-44.0%
0.00%
-50.0%
Q4 2013$1,706,000
+4.2%
40,485
-1.5%
0.00%0.0%
Q3 2013$1,638,000
-23.3%
41,090
-20.5%
0.00%
-33.3%
Q2 2013$2,136,00051,6770.01%
Other shareholders
HAEMONETICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders